Melanoma Trial, Recruiting (NCT06970236)

Melanoma Trial, Recruiting NCT06970236 Sponsor: University of Valencia Condition: Melanoma

Printed from Voxsanity (voxsanity.com.au) — NCT06970236 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Melanoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults who have been diagnosed with Choroidal Melanoma (a type of eye cancer) and are being treated with a specific radiation therapy called plaque brachytherapy at the Hospital Universitari i Politècnic La Fe in Valencia, Spain.

Who may not be able to join:

People whose current health condition means it would not be safe for them to take part in high-intensity resistance (strength) training.
People who have an unstable or unpredictable heart condition.
People who have a serious disorder affecting the body's metabolism (how the body processes energy and nutrients).
People who have a significant bone or joint problem that would prevent them from doing exercise.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06970236

Sponsor: University of Valencia

Phase: Not Applicable

Status: Recruiting

Condition: Melanoma

More information: https://clinicaltrials.gov/study/NCT06970236

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults who have been diagnosed with Choroidal Melanoma (a type of eye cancer) and are being treated with a specific radiation therapy called plaque brachytherapy at the Hospital Universitari i Politècnic La Fe in Valencia, Spain.

Who may not be able to join:

People whose current health condition means it would not be safe for them to take part in high-intensity resistance (strength) training.
People who have an unstable or unpredictable heart condition.
People who have a serious disorder affecting the body's metabolism (how the body processes energy and nutrients).
People who have a significant bone or joint problem that would prevent them from doing exercise.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Valencia

Registry

ClinicalTrials.gov

Start date

1 February 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Blood biomarkers: glucose; Blood biomarkers: urea; Blood biomarkers: creatinine; Blood biomarkers: glomerular filtration; Blood biomarkers: total bilirubin; Blood biomarkers: aspartate aminotransferase; Blood biomarkers: alanine aminotransferase; Blood biomarkers: alkaline phosphatase; Blood biomarkers: lactate dehydrogenase; Blood biomarkers: creatine kinase; Blood biomarkers: total proteins; Blood biomarkers: albumin; Blood biomarkers: C-reactive protein; Blood biomarkers: interleukin 6; Blood biomarkers: calcium; Blood biomarkers: albumine-corrected calcium; Blood biomarkers: chloride; Bloo...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov